ScholarIQanswers from OpenAlex

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients

PaperCitations, authors & open-access status

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients have?

ScholarIQcitation count

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients has 87 citations in the OpenAlex counts ScholarIQ stores.

When was Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients published?

ScholarIQyear

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients has 2017 year in the ScholarIQ index.

What is the open-access status of Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients?

ScholarIQoa status

Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients has gold oa status in the ScholarIQ index.

What is the DOI of Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients?

ScholarIQdoi

The DOI for Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients is on the source record.

What is the PMID of Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients?

ScholarIQpmid

The PMID for Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients is on the source record.

What is the OpenAlex record for Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients?

ScholarIQopenalex

The OpenAlex for Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial